Yan Moore

Yan Moore, MD, MBA is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as Chief Medical Officer at Omega Therapeutics since January 2022, where the focus is on developing programmable, engineered mRNA therapeutics. In addition, Yan Moore holds board member positions at NanoGhost and serves as an advisory board member for TriSalus Life Sciences. Previous roles include Senior Vice President at Ipsen, Chief Medical Officer at Anchiano Therapeutics, and Vice President of Global Medical Affairs at ARIAD Pharmaceuticals. Educational credentials include an MD from Tel Aviv University, an MBA from Drexel University, and executive management training from Harvard Business School and London Business School.